Dexamethasone Sodium Phosphate Injection
Product Images NDC 51662-1660

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 51662-1660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1660 Structure)

Structure (51662 1660 Structure)
Chemical structure of dexamethasone sodium phosphate shown as a molecular diagram, including the steroid backbone and phosphate groups with sodium ions.*
FDA Label Image

Vial Label (51662 1660 1 Vial Label)

Vial Label (51662 1660 1 Vial Label)
Label for Dexamethasone Sodium Phosphate Injection, USP 20 mg per 5 mL (4 mg/mL) by HF Acquisition Co LLC, DBA HealthFirst. The label indicates dosage strength, usage instructions for intra-articular or soft tissue injection, vial size of 5 mL, storage directions, and manufacturer information including location in Hackensack, NJ.*
FDA Label Image

Rfid Label (51662 1660 1 Vial Rfid)

Rfid Label (51662 1660 1 Vial Rfid)
DataMatrix barcode label showing serialized product and lot information for Dexamethasone Sodium Phosphate injection. The label includes GS1 formatted strings with GTIN, expiration date, and lot number, and notes distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label instructs to see manufacturer's insert for details.*
FDA Label Image

Pouch Label (51662 1660 2 Pouch Label)

Pouch Label (51662 1660 2 Pouch Label)
Dexamethasone Sodium Phosphate Injection, USP 20 mg/5 mL (4 mg/mL) in a 5 mL vial. The label indicates use for intravenous, intramuscular, intralesional, intra-articular, or soft tissue administration. Manufactured by HF Acquisition Co., LLC. The label includes storage instructions and formulation details, including preservatives and pH range.*
FDA Label Image

Rfid Label (51662 1660 3 Case)

Rfid Label (51662 1660 3 Case)
Label for Dexamethasone Sodium Phosphate Injection USP 20 mg/5 mL (4 mg/mL) in a 5 mL vial, sold as a case of 10 vials. The label specifies routes of administration including intravenous, intramuscular, intralesional, intra-articular, and soft tissue. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Storage instructions include keeping at 20 to 25°C, avoiding freezing and light exposure. The product is Rx only.*
FDA Label Image

Case Label (51662 1660 3 Case Label)

Case Label (51662 1660 3 Case Label)
Label for Dexamethasone Sodium Phosphate injection, showing a barcode and multiple lines of numeric data including identifiers likely related to product tracking. The label includes text referencing the manufacturer insert and lists HF Acquisitions Co., LLC, Mukilteo, WA 98275 as the distributor. The label is affixed on a gray surface.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.